COMMUNIQUÉS West-GlobeNewswire

-
STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024
23/10/2024 -
Clover Health to Report Third Quarter 2024 Financial Results on November 6
23/10/2024 -
Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30
23/10/2024 -
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
23/10/2024 -
New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo
23/10/2024 -
WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call
23/10/2024 -
Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference
23/10/2024 -
Cytokinetics to Announce Third Quarter Results on November 6, 2024
23/10/2024 -
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
23/10/2024 -
Dans le cadre de la GHE 2024, le KFSHRC célèbre 40 ans de leadership dans le domaine des cellules souches
23/10/2024 -
Lung Health Foundation: New Evict Radon National Study Report Underscores ‘Urgent Need for Canada-Wide Advocacy’ to Reduce Dangerous Radon Levels in Canadian Homes
23/10/2024 -
Ancilia Biosciences Selected to Receive $3 Million Award from ARPA-H’s Sprint for Women’s Health
23/10/2024 -
Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health
23/10/2024 -
Saudi Surgeon Honored for Performing the World’s First Fully Robotic Heart Transplant
23/10/2024 -
Orchard Therapeutics Announces Multiple Data Presentations and Publications
23/10/2024 -
Le KFSHRC honore 28 scientifiques figurant sur la liste de Stanford des 2 % des chercheurs les plus cités
23/10/2024 -
BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference
23/10/2024 -
Rapafusyn Announces an Upcoming Oral Presentation at Targeted Protein Degradation & Induced Proximity Summit
23/10/2024 -
Le KFSHRC s’impose comme le plus important programme de transplantation rénale par don croisé au monde, avec 500 transplantations réussies
23/10/2024
Pages